Form 8-K - Current report:
SEC Accession No. 0001401914-23-000042
Filing Date
2023-07-21
Accepted
2023-07-21 16:01:36
Documents
12
Period of Report
2023-07-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K dare-20230719.htm   iXBRL 8-K 27530
  Complete submission text file 0001401914-23-000042.txt   152790

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20230719.xsd EX-101.SCH 1923
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20230719_lab.xml EX-101.LAB 23894
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20230719_pre.xml EX-101.PRE 12541
6 EXTRACTED XBRL INSTANCE DOCUMENT dare-20230719_htm.xml XML 2702
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 231102539
SIC: 2834 Pharmaceutical Preparations